373 related articles for article (PubMed ID: 15578064)
1. Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo.
Chien PY; Wang J; Carbonaro D; Lei S; Miller B; Sheikh S; Ali SM; Ahmad MU; Ahmad I
Cancer Gene Ther; 2005 Mar; 12(3):321-8. PubMed ID: 15578064
[TBL] [Abstract][Full Text] [Related]
2. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer.
Yano J; Hirabayashi K; Nakagawa S; Yamaguchi T; Nogawa M; Kashimori I; Naito H; Kitagawa H; Ishiyama K; Ohgi T; Irimura T
Clin Cancer Res; 2004 Nov; 10(22):7721-6. PubMed ID: 15570006
[TBL] [Abstract][Full Text] [Related]
4. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo.
He XW; Liu T; Chen YX; Cheng DJ; Li XR; Xiao Y; Feng YL
Cancer Gene Ther; 2008 Mar; 15(3):193-202. PubMed ID: 18202713
[TBL] [Abstract][Full Text] [Related]
5. Systemic delivery of RafsiRNA using cationic cardiolipin liposomes silences Raf-1 expression and inhibits tumor growth in xenograft model of human prostate cancer.
Pal A; Ahmad A; Khan S; Sakabe I; Zhang C; Kasid UN; Ahmad I
Int J Oncol; 2005 Apr; 26(4):1087-91. PubMed ID: 15754006
[TBL] [Abstract][Full Text] [Related]
6. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis.
Khoury M; Louis-Plence P; Escriou V; Noel D; Largeau C; Cantos C; Scherman D; Jorgensen C; Apparailly F
Arthritis Rheum; 2006 Jun; 54(6):1867-77. PubMed ID: 16729293
[TBL] [Abstract][Full Text] [Related]
7. Liver-targeted gene transfer into a human hepatoblastoma cell line and in vivo by sterylglucoside-containing cationic liposomes.
Hwang SH; Hayashi K; Takayama K; Maitani Y
Gene Ther; 2001 Aug; 8(16):1276-80. PubMed ID: 11509962
[TBL] [Abstract][Full Text] [Related]
8. Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.
Pirollo KF; Rait A; Zhou Q; Hwang SH; Dagata JA; Zon G; Hogrefe RI; Palchik G; Chang EH
Cancer Res; 2007 Apr; 67(7):2938-43. PubMed ID: 17409398
[TBL] [Abstract][Full Text] [Related]
9. Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes.
Sonoke S; Ueda T; Fujiwara K; Sato Y; Takagaki K; Hirabayashi K; Ohgi T; Yano J
Cancer Res; 2008 Nov; 68(21):8843-51. PubMed ID: 18974128
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal gene delivery mediated by a novel cationic liposome in a peritoneal disseminated ovarian cancer model.
Lee MJ; Cho SS; You JR; Lee Y; Kang BD; Choi JS; Park JW; Suh YL; Kim JA; Kim DK; Park JS
Gene Ther; 2002 Jul; 9(13):859-66. PubMed ID: 12080380
[TBL] [Abstract][Full Text] [Related]
11. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
Xiao W; Chen X; Yang L; Mao Y; Wei Y; Chen L
Int J Pharm; 2010 Jun; 393(1-2):119-26. PubMed ID: 20416367
[TBL] [Abstract][Full Text] [Related]
13. Highly efficient cationic hydroxyethylated cholesterol-based nanoparticle-mediated gene transfer in vivo and in vitro in prostate carcinoma PC-3 cells.
Hattori Y; Ding WX; Maitani Y
J Control Release; 2007 Jul; 120(1-2):122-30. PubMed ID: 17512626
[TBL] [Abstract][Full Text] [Related]
14. Rapid delivery of small interfering RNA by biosurfactant MEL-A-containing liposomes.
Inoh Y; Furuno T; Hirashima N; Kitamoto D; Nakanishi M
Biochem Biophys Res Commun; 2011 Oct; 414(3):635-40. PubMed ID: 22001930
[TBL] [Abstract][Full Text] [Related]
15. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications.
Dalby B; Cates S; Harris A; Ohki EC; Tilkins ML; Price PJ; Ciccarone VC
Methods; 2004 Jun; 33(2):95-103. PubMed ID: 15121163
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cationic liposome-mediated transfection using the DNA-binding peptide mu (mu) from the adenovirus core.
Murray KD; Etheridge CJ; Shah SI; Matthews DA; Russell W; Gurling HM; Miller AD
Gene Ther; 2001 Mar; 8(6):453-60. PubMed ID: 11313824
[TBL] [Abstract][Full Text] [Related]
17. Gene delivery into hepatocytes with the preS/liposome/DNA system.
Wang Z; Yuan Z; Jin L
Biotechnol J; 2008 Oct; 3(9-10):1286-95. PubMed ID: 18830969
[TBL] [Abstract][Full Text] [Related]
18. In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery.
Egilmez NK; Cuenca R; Yokota SJ; Sorgi F; Bankert RB
Gene Ther; 1996 Jul; 3(7):607-14. PubMed ID: 8818648
[TBL] [Abstract][Full Text] [Related]
19. Anionic amino acid-derived cationic lipid for siRNA delivery.
Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
[TBL] [Abstract][Full Text] [Related]
20. The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex.
Tagami T; Barichello JM; Kikuchi H; Ishida T; Kiwada H
Int J Pharm; 2007 Mar; 333(1-2):62-9. PubMed ID: 17097247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
